The largest database of trusted experimental protocols

22 protocols using fitc lps

1

Establishment and Characterization of Macrophage Cell Models

Check if the same lab product or an alternative is used in the 5 most similar protocols
RAW264.7 cells were obtained from China Center for Type Culture Collection (Wuhan, China). All cell lines have been authenticated using STR profiling and tested for mycoplasma contamination. RAW264.7 cells were cultured in RPMI 1640 medium containing 10% fetal bovine serum. BMDCs were harvested after 7 days of culture with GM-CSF (20 ng/mL; PeproTech, Rocky Hill, NJ, USA) and IL-4 (10 ng/mL; PeproTech), and BMDMs with M-CSF (50 ng/mL, PeproTech). The purity of BMDCs and BMDMs was more than 90% assessed by flow cytometry. Atg7-knockdown BMDCs (Atg7 KD) were established by siRNA (Ribobio) transfection using riboFECT reagent (Ribobio). LPS (0111:B4, L3024, Sigma-Aldrich), FITC-LPS (0111:B4, F3665, Sigma-Aldrich), z-VAD-fmk (HY-16658B, MedChemExpress), Erastin (E7781, Sigma-Aldrich), Ferrostatin-1 (SML0583, Sigma-Aldrich), Rapamycin (V900930, Sigma-Aldrich), Chloroquine (C6628, Sigma-Aldrich) were supplemented into culture medium respectively in the following experiments.
+ Open protocol
+ Expand
2

Binding of LPS and WTA in Bacteria

Check if the same lab product or an alternative is used in the 5 most similar protocols
To detect the binding of LPS from P. aeruginosa to S. aureus, FITC-LPS (Sigma-Aldrich, United States) and free LPS (Sigma-Aldrich, United States) were mixed with 105 CFU of S. aureus. The fluorescence intensity was detected, and the number of S. aureus SA113 bound to FITC-LPS was enumerated with a Guava easyCyte flow cytometer (Merck Millipore). To assess the binding of WTA of S. aureus or free lipoteichoic acids (LTA; Sigma-Aldrich, United States) to P. aeruginosa, mid-log phase S. aureus and P. aeruginosa were stained with hexidium iodide (Thermo Fisher Scientific, Waltham, MA, United States) and SYTO 9 (Invitrogen; Thermo Fisher Scientific) according to the instruction provided by the vendors. Labeled S. aureus and P. aeruginosa were mixed at a ratio of 1:1 and 105 CFU/ml of the bacteria was used for flow cytometry analysis. Five thousand fluorescent-stained cells were counted in a gate set in a hexidium iodide versus SYTO 9 dot plot.
+ Open protocol
+ Expand
3

Endotoxin Distribution in Pregnant Mice

Check if the same lab product or an alternative is used in the 5 most similar protocols
In order to observe the distribution of endotoxin in pregnant mice, 20 mg/kg fluorescein isothiocyanate labeled LPS (FITC-LPS, Sigma Company, USA) [19 (link)] was given on the 18th day and performed fluorescence imaging through the small animal in vivo imaging system. The pregnant mice in each group were given FITC-LPS on the 18th day of pregnancy, and fluorescence imaging was performed on the in vivo fluorescence imaging system (LB983, Berto, Germany) after intragastric administration 6–7 h.
+ Open protocol
+ Expand
4

Lipid-Mediated Gene Delivery Optimization

Check if the same lab product or an alternative is used in the 5 most similar protocols
Poly(D,L-lactide-co-glycolide) (Resomer® RG 503H, free carboxylic acid, MW 24–38 kD), dichloromethane, polyvinyl alcohol (PVA, MW 30–70 kD, 87–90% hydrolyzed), polyethylenimine (linear, MW 2.5 kD), poloxamer 407, class B CpG ODN 2007 (phosphorothioate backbone modified with a sequence of 5'-TCGTCGTTGTCGTTTTGTCGTT-3' and its non-CpG ODN form, FITC-LPS (derived from Escherichia coli O111:B4) and lipopolysaccharide (LPS) (derived from Escherichia coli O111:B4, TLR ligand tested) were obtained from Sigma-Aldrich (Oakville, ON, Canada). Pam3CSK4 and Rhodamine-Pam3CSK4 (endotoxin level tested) were obtained from InvivoGen (San Diego, CA, USA). Quant-iT™ OliGreen® ssDNA reagent was from Life Technologies.
+ Open protocol
+ Expand
5

Evaluating LPS and Cytokine Binding of M-Se@SiO2

Check if the same lab product or an alternative is used in the 5 most similar protocols
To evaluate the LPS- and cytokine-binding ability of M-Se@SiO2, M-Se@SiO2 (1 mg/mL) were mixed with PBS containing 10% FBS and FITC-LPS (Sigma, 100 ng/mL), TNF-α (85 pg/mL), or IL-6 (360 pg/mL) at 37 °C for 30 min. The samples were centrifuged at 16,000 × g for 15 min to remove the nanospheres. LPS remaining in the supernatant was measured as the fluorescence intensity, and cytokines in the supernatant were quantified by ELISA (Anogen, Canada).
+ Open protocol
+ Expand
6

Molecular Pathways Modulation in Inflammation

Check if the same lab product or an alternative is used in the 5 most similar protocols
Alginate, LPS, PMB, FITC-phalloidin, FITC-LPS and 4′,6-diamidino-2-phenylindole (DAPI) were obtained from Sigma-Aldrich (St. Louis, MO, USA). RPMI-1640 medium, Dulbecco’s modified Eagle’s medium (DMEM), penicillin and streptomycin were purchased from Hyclone (Logan, UT, USA). Foetal bovine serum (FBS) was obtained from Biological Industries (Beit-Haemek, Israel). Anti-mouse TLR4, MD2, MyD88, F4/80 and Ly6G antibodies were from purchased Abcam (Cambridge, UK). Antibodies against Akt, phosphor-Akt (p-Akt), NF-κB p65, IκB, phosphor-IκB (p-IκB), mTOR, phosphor-mTOR (p-mTOR), p70 S6 kinase (p70 S6K), phosphor-p70 S6K (p-p70 S6K), p38, phosphor-p38 (p-p38), JNK, phosphor-JNK (p-JNK), ERK, phosphor-ERK (p-ERK) and iNOS were purchased from Cell Signaling Technology (Beverly, MA, USA). Anti-β-actin, -β-tubulin, -GAPDH and -Lamin B1 antibodies were purchased from Proteintech (Hubei, China). Inhibitors LY 294002, SB 20358, SP 600125 and PD 98059 were obtained from Selleck (Shanghai, China) and TAK-242 and rapamycin from Invitrogen (Carlsbad, CA, USA). The other chemicals were all purchased from Macklin Biochemical Technology (Shanghai, China).
+ Open protocol
+ Expand
7

Gal8 Modulates LPS Uptake in BMDMs

Check if the same lab product or an alternative is used in the 5 most similar protocols
BMDMs pretreated with rGal8 (20μg/mL in DMEM) for 30 min as described above were incubated with FITC-LPS (Sigma, 100 ng/mL in DMEM, 1h, 37°C), cells were washed twice with cold PBS, sequentially stained with PE-MD-2/TLR4 complex antibody (dilution1:100, clone MTS510, eBioscience) and a viability dye, and then processed for flow cytometry.
+ Open protocol
+ Expand
8

Gal-8 Modulates LPS Binding to CD14 in BMDMs

Check if the same lab product or an alternative is used in the 5 most similar protocols
Since CD14 is the key LPS binding protein on BMDMs, to determine the effect of Gal-8 on LPS binding to CD14, serum starved BMDMs in 100 mm petri dishes were treated with rGal8 (20ug/mL in DMEM) for 30 min, FITC-LPS (Sigma, 100 ng/mL in DMEM) was added and plates were incubated for additional 1 hour at 37°C. Plates were then washed 3 times with cold PBS to remove any traces of unbound LPS, stained with a viability dye and were then processed for flow cytometry to detect bound FITC-LPS. Cells were acquired by BD LSRII, and data analyzed by FlowJo.
+ Open protocol
+ Expand
9

Isolation and Labeling of Bacterial LPS

Check if the same lab product or an alternative is used in the 5 most similar protocols
LA, A6 and their fragments were obtained from Innovate Biopharmaceuticals, Inc. (Raleigh, NC). LPS from Escherichia coli serotype 0111: B4 labeled with FITC (FITC-LPS) was purchased from Sigma.
+ Open protocol
+ Expand
10

Investigating EV-LPS Binding and Effects

Check if the same lab product or an alternative is used in the 5 most similar protocols
10 µg M0φ‐EVs or M2φ‐EVs were mixed with FITC‐LPS (Sigma, USA) according to these different ratios of 10:0.5–10:64 for 1 h at 37°C in PBS, with a final volume of 100 µL (Kumari et al., 2023 (link)). For detection of the binding ability of EVs and LPS by flow cytometry, all the unbound LPS in each mixture was removed by UC at 120,000 × g for 30 min at 4°C, and the pellets were resuspended in PBS for further analysis; for detection of the effect of EV‐bound LPS, the above mixtures of EVs and LPS, LPS or LPS transfection were directly added to MH‐S cells for 24 h. After incubation, the treated cells and supernatant were collected for further analysis.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!